glp-1 drugs for type 1 diabetes The ABC's of GLP-1s: Benefits, Side Effects, and Success Stories — Nice Healthcare GLP-1 Agonists: A Comprehensive Overview
Description
Major cardiovascular outcome trials, including LEADER, SUSTAIN-6, and REWIND, followed patients for several years
The FDA includes all the GLP-1s from above in the same medicine classification and is evaluating reports of suicidal thoughts or actions in people taking GLP-1s
Parkinsons Foundation
These reflect brand-reported data and are not independently audited
129 Further, the onset age 130 and duration of diabetes mellitus 131 may have some influence on synaptic plasticity
It was argued that therapeutic guidelines fail to achieve sustained HbA 1c reductions and therefore treatment should be based on addressing pathophysiological defects [8]
